KRTL Biotech Expands Regulatory and Partner-Qualification Framework for South American API and Controlled-Substance Pharmaceutical Development
KRTL Biotech expands its South American API and controlled-substance strategy, advancing coca-derived extracts, regulatory pathways and consulting.